ANI Pharmaceuticals
ANIP
$65.36
Share price
0.63%
Change (1 day)
75.27%
Change (1 year)
Categories
ANI Pharmaceuticals (ANIP) - P/B ratio
P/B ratio as of April 2024 : 3.00
According to ANI Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 3.00.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ANI Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.46 | 18.67% |
| 2022-12-31 | 2.07 | -3.13% |
| 2021-12-31 | 2.14 | 16.7% |
| 2020-12-31 | 1.83 | -47.68% |
| 2019-12-31 | 3.51 | 29.54% |
| 2018-12-31 | 2.71 | -37.01% |
| 2017-12-31 | 4.30 | 3.77% |
| 2016-12-31 | 4.14 | 27.67% |
| 2015-12-31 | 3.24 | -29.45% |
| 2014-12-31 | 4.60 | -2.6% |
| 2013-12-31 | 4.72 | 341.64% |
| 2012-12-31 | 1.07 | -26.81% |
| 2011-12-31 | 1.46 | -79.15% |
| 2010-12-31 | 7.00 | 42.54% |
| 2009-12-31 | 4.91 | 147.68% |
| 2008-12-31 | 1.98 | -42.61% |
| 2007-12-31 | 3.46 | -3.48% |
| 2006-12-31 | 3.58 | -65.51% |
| 2005-12-31 | 10.4 | 55.93% |
| 2004-12-31 | 6.66 | 0.11% |
| 2003-12-31 | 6.65 | 7.11% |
| 2002-12-31 | 6.21 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 4.25 | 41.94% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.61 | -46.26% | 🇺🇸 USA |
 Cardinal Health CAH | -7.29 | -343.28% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | 1.83 | -39.06% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | -1.51 | -150.24% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 5.56 | 85.46% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.92 | -35.76% | 🇮🇱 Israel |
 Royalty Pharma RPRX | 1.66 | -44.64% | 🇬🇧 UK |
 Lannett Company LCI | -0.0179 | -100.60% | 🇺🇸 USA |